QFR-Guided Percutaneous Coronary Intervention Improves Outcomes
One-year clinical outcomes improved with quantitative flow ratio for lesion selection versus standard angiography guidance.
One-year clinical outcomes improved with quantitative flow ratio for lesion selection versus standard angiography guidance.
Researchers evaluated the safety and efficacy of transradial vs transfemoral access in patients with CKD undergoing PCI.
The triglyceride-glucose index (TyG index) is an ineffective predictive factor for cardiovascular prognosis in patients without diabetes who underwent percutaneous coronary intervention.
Personalized antiplatelet therapy using platelet function testing can decrease ischemic events in stable CAD.
A meta-analysis did not demonstrate a benefit of beta-blockers in reducing major adverse cardiovascular events in a population of patients with stable coronary artery disease without previous history of myocardial infarction or left ventricular dysfunction.
Smoking and obesity associated with significantly earlier age of presentation.
Patients with systemic sclerosis and systemic lupus erythematosus were found to be at increased odds of adverse clinical outcomes and bleeding, respectively, after percutaneous coronary intervention.
Impaired renal function was found to have negative long-term effects in individuals with acute coronary syndrome after percutaneous coronary intervention.
Several factors were found to be associated with the development of contrast-induced nephropathy after percutaneous coronary intervention in patients with ST-elevation myocardial infarction (STEMI) and non-ST-elevation acute coronary syndrome.
Patients with vs without cancer were found to be at an increased risk for cardiac mortality and bleeding after undergoing a percutaneous coronary.